Abstract
Background
Gastroparesis is a debilitating functional disorder of the stomach marked by delayed gastric emptying in the absence of mechanical obstruction. Patients with severe, refractory symptoms may ultimately be managed with Roux-en-Y reconstruction; however, it is unclear whether the stomach should be left in situ, similar to a conventional gastric bypass, or resected as in gastrectomy.
Methods
All patients undergoing Roux-en-Y for the treatment of gastroparesis (GP) at our institution from September 2010 through March 2018 were retrospectively reviewed. Patients with prior gastric resection or whose primary operative indication was not gastroparesis were excluded from analysis.
Results
Twenty-six patients underwent Roux-en-Y with stomach left in situ (RY-SIS) and twenty-seven patients underwent gastrectomy with Roux-en-Y reconstruction during the study period. The mean age was 49.7 years in the RY-SIS cohort and 48.5 years in the gastrectomy cohort. Etiology of GP was similar between the two cohorts. Patients undergoing gastrectomy were more likely to have previous interventions for GP (63.0% vs. 26.9%). RY-SIS was associated with a shorter operative time (155 vs. 223 min), less blood loss (24 vs. 130 mL), and shorter length of stay (4.0 vs. 7.2 days). Twelve patients (44.4%) had complications within 30 days following gastrectomy compared to two patients (7.7%) following RY-SIS (p = 0.001). Patients in the RY-SIS cohort were more likely to require further subsequent surgical intervention for GP (23.1% vs. 3.7%, p = 0.04). At last follow-up, there were no differences in reported GP symptoms or symptom scoring.
Conclusions
Gastrectomy was associated with greater perioperative morbidity compared to leaving the stomach in situ. Symptomatic improvement at intermediate follow-up was equivalent following either procedure. However, patients undergoing RY-SIS were more likely to require subsequent surgical intervention, suggesting that gastrectomy may be a more definitive operation for the management of medically refractory gastroparesis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hasler WL (2007) Gastroparesis: symptoms, evaluation, and treatment. Gastroenterol Clin N Am 36:619–647
Shen S, Xu J, Lamm V, Vachaparambil CT, Chen H, Cai Q (2019) Diabetic gastroparesis and nondiabetic gastroparesis. Gastrointest Endosc Clin N Am 29:15–25. https://doi.org/10.1016/j.giec.2018.08.002
Homko CJ, Duffy F, Friedenberg FK, Boden G, Parkman HP (2015) Effect of dietary fat and food consistency on gastroparesis symptoms in patients with gastroparesis. Neurogastroenterol Motil 27:501–508. https://doi.org/10.1111/nmo.12519
Myint AS, Rieders B, Tashkandi M, Borum ML, Koh JM, Stephen S, Doman DB (2018) Current and emerging therapeutic options for gastroparesis. Gastroenterol Hepatol 14:639–645
Shada AL, Dunst CM, Pescarus R, Speer EA, Cassera M, Reavis KM, Swanstrom LL (2016) Laparoscopic pyloroplasty is a safe and effective first-line surgical therapy for refractory gastroparesis. Surg Endosc 30:1326–1332. https://doi.org/10.1007/s00464-015-4385-5
Lal N, Livemore S, Dunne D, Khan I (2015) Gastric electrical stimulation with the enterra system: a systematic review. Gastroenterol Res Pract 2015:9. https://doi.org/10.1155/2015/762972
Mancini SA, Angelo JL, Peckler Z, Philp FH, Farah KF (2015) Pyloroplasty for refractory gastroparesis. Am Surg 81:738–746
Gonzalez JM, Benezech A, Vitton V, Barthet M (2017) G-POEM with antro-pyloromyotomy for the treatment of refractory gastroparesis: mid-term follow-up and factors predicting outcome. Aliment Pharmacol Ther 46:364–370. https://doi.org/10.1111/apt.14132
Rodriguez J, Strong AT, Haskins IN, Landreneau JP, Allemang MT, El-Hayek K, Villamere J, Tu C, Cline MS, Kroh M, Ponsky JL (2018) Per-oral pyloromyotomy (POP) for medically refractory gastroparesis: short term results from the first 100 patients at a high volume center. Ann Surg 268:421–430. https://doi.org/10.1097/SLA.0000000000002927
Wakamatsu K, Perez Quirante F, Montorfano L, Lo Menzo E, Seto Y, Rosenthal RJ (2018) Laparoscopic treatment of gastroparesis: a single center experience. Surg Obes Relat Dis 14:200–205
McCallum RW, Polepalle SC, Schirmer B (1991) Completion gastrectomy for refractory gastroparesis following surgery for peptic ulcer disease. Long-term follow-up with subjective and objective parameters. Dig Dis Sci 36:1556–1561
Abell TL, Camilleri M, Donohoe K, Hasler WL, Lin HC, Maurer AH, McCallum RW, Nowak T, Nusynowitz ML, Parkman HP, Shreve P, Szarka LA, Snape WJ, Ziessman HA, American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine (2008) Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol 103:753–763. https://doi.org/10.1111/j.1572-0241.2007.01636.x
Revicki DA, Rentz AM, Dubois D, Kahrilas P, Stanghellini V, Talley NJ, Tack J (2004) Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res 13:833–844. https://doi.org/10.1023/B:QURE.0000021689.86296.e4
Strong AT, Landreneau JP, Cline M, Kroh MD, Rodriguez JH, Ponsky JL, El-Hayek K (2019) Per-oral pyloromyotomy (POP) for medically refractory post-surgical gastroparesis. J Gastrointest Surg. https://doi.org/10.1007/s11605-018-04088-7
Landreneau JP, Strong AT, El-Hayek K, Tu C, Villamere J, Ponsky JL, Kroh MD, Rodriguez JH (2019) Laparoscopic pyloroplasty versus endoscopic per-oral pyloromyotomy for the treatment of gastroparesis. Surg Endosc 33:773–781. https://doi.org/10.1007/s00464-018-6342-6
Watkins PJ, Buxton-Thomas MS, Howard ER (2003) Long-term outcome after gastrectomy for intractable diabetic gastroparesis. Diabet Med 20:58–63
Papasavas PK, Ng JS, Stone AM, Ajayi OA, Muddasani KP, Tishler DS (2014) Gastric bypass surgery as treatment of recalcitrant gastroparesis. Surg Obes Relat Dis 10:795–799. https://doi.org/10.1016/j.soard.2014.01.013
Speicher JE, Thirlby RC, Burggraaf J, Kelly C, Levasseur S (2009) Results of completion gastrectomies in 44 patients with postsurgical gastric atony. J Gastrointest Surg 13:874–880. https://doi.org/10.1007/s11605-009-0821-y
Bhayani NH, Sharata AM, Dunst CM, Kurian AA, Reavis KM, Swanstrom LL (2015) End of the road for a dysfunctional end organ: laparoscopic gastrectomy for refractory gastroparesis. J Gastrointest Surg 19:411–417. https://doi.org/10.1007/s11605-014-2609-y
Sun Z, Rodriguez J, McMichael J, Chand B, Nash D, Brethauer S, Schauer P, El-Hayek K, Kroh M (2015) Surgical treatment of medically refractory gastroparesis in the morbidly obese. Surg Endosc 29:2683–2689. https://doi.org/10.1007/s00464-014-3990-z
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Matthew D. Kroh has no conflict of interest relevant to this publication. Outside of the scope of this work, he serves as a consultant for Levita Magnetics and Medtronic. He has received research funding from Cook. John H. Rodriguez has no conflict of interest relevant to this publication. Outside of the scope of this publication, he has received research funding from Pacira Pharmaceuticals and Intuitive Surgical. Joshua P. Landreneau, Andrew Strong, Kevin El-Hayek have no conflict of interest or financial ties to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Landreneau, J.P., Strong, A.T., El-Hayek, K. et al. Gastrectomy versus stomach left in situ with Roux-en-Y reconstruction for the treatment of gastroparesis. Surg Endosc 34, 1847–1855 (2020). https://doi.org/10.1007/s00464-019-06951-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-019-06951-3